Authors


Manfred Karner

Latest:

Collaborating for Efficiency and Safety in Raw Material Inspection

By working together and taking a QA-based approach, manufacturers and suppliers can reduce raw material testing requirements.


Gil Roth

Latest:

CDMOs: New Administration, New Frontier

Despite some progress, the industry is still in a wait-and-see mode regarding the administration, Congress, and FDA.


James D. Colandene

Latest:

Stage 2 Process Validation: Regulatory Expectations and Approaches to Determine and Justify the Number of PPQ Batches

The authors summarize the current regulatory expectations regarding the number of PPQ batches required and provide potential approaches that can be used to determine and justify the number of PPQ batches.


Douglas P. Nesta

Latest:

Stage 2 Process Validation: Regulatory Expectations and Approaches to Determine and Justify the Number of PPQ Batches

The authors summarize the current regulatory expectations regarding the number of PPQ batches required and provide potential approaches that can be used to determine and justify the number of PPQ batches.


Kashappa Goud Desai

Latest:

Stage 2 Process Validation: Regulatory Expectations and Approaches to Determine and Justify the Number of PPQ Batches

The authors summarize the current regulatory expectations regarding the number of PPQ batches required and provide potential approaches that can be used to determine and justify the number of PPQ batches.


David Steil

Latest:

How to Select Pharmaceutical Dust Collectors in Accordance with the New ASHRAE Standard 199

The pharmaceutical industry now has a way to accurately evaluate and compare dust collection systems that are self-cleaning


Ron Majors

Latest:

Innovations and Future Trends in HPLC Column Technology

Developments in chromatography column technology to deliver greater efficiency, speed and inertness benefit the drug development process from discovery to manufacturing and quality control.


Beata Vladovicova

Latest:

Advancements in Extrusion-Spheronization

More agile techniques are improving the development of multiparticulate drug-delivery systems.



Fenghe Qiu

Latest:

Risk-Based Predictive Stability for Pharmaceutical Development–A Proposed Regulatory Template

A published regulatory template sharing best practices for filing RBPS data would benefit the industry and regulatory reviewers by enabling a consistent presentation of predictive data and conclusions.


Yan Wu

Latest:

Risk-Based Predictive Stability–An Industry Perspective

A survey on risk-based predictive stability tools reveals how pharma companies are leveraging advanced stability approaches throughout the drug development process.


David Hahn

Latest:

Risk-Based Predictive Stability–An Industry Perspective

A survey on risk-based predictive stability tools reveals how pharma companies are leveraging advanced stability approaches throughout the drug development process.


Megan McMahon

Latest:

Risk-Based Predictive Stability for Pharmaceutical Development–A Proposed Regulatory Template

A published regulatory template sharing best practices for filing RBPS data would benefit the industry and regulatory reviewers by enabling a consistent presentation of predictive data and conclusions.


Rachel Orr

Latest:

Risk-Based Predictive Stability–An Industry Perspective

A survey on risk-based predictive stability tools reveals how pharma companies are leveraging advanced stability approaches throughout the drug development process.


Debra Webb

Latest:

Risk-Based Predictive Stability–An Industry Perspective

A survey on risk-based predictive stability tools reveals how pharma companies are leveraging advanced stability approaches throughout the drug development process.


Elke Debie

Latest:

Risk-Based Predictive Stability for Pharmaceutical Development–A Proposed Regulatory Template

A published regulatory template sharing best practices for filing RBPS data would benefit the industry and regulatory reviewers by enabling a consistent presentation of predictive data and conclusions.


Lois Sechler

Latest:

Risk-Based Predictive Stability–An Industry Perspective

A survey on risk-based predictive stability tools reveals how pharma companies are leveraging advanced stability approaches throughout the drug development process.


Helen Williams

Latest:

Risk-Based Predictive Stability for Pharmaceutical Development–A Proposed Regulatory Template

A published regulatory template sharing best practices for filing RBPS data would benefit the industry and regulatory reviewers by enabling a consistent presentation of predictive data and conclusions.


Dennis Stephens

Latest:

Risk-Based Predictive Stability for Pharmaceutical Development–A Proposed Regulatory Template

A published regulatory template sharing best practices for filing RBPS data would benefit the industry and regulatory reviewers by enabling a consistent presentation of predictive data and conclusions.


Cherokee Hoaglund Hyzer

Latest:

Risk-Based Predictive Stability for Pharmaceutical Development–A Proposed Regulatory Template

A published regulatory template sharing best practices for filing RBPS data would benefit the industry and regulatory reviewers by enabling a consistent presentation of predictive data and conclusions.



Yueer Shi

Latest:

Covalidation Strategies to Accelerate Analytical Method Transfer for Breakthrough Therapies

The primary impact of using the covalidation model is the expedited analytical method qualification of both the transferring and receiving laboratories.


Nicola Hulme

Latest:

Covalidation Strategies to Accelerate Analytical Method Transfer for Breakthrough Therapies

The primary impact of using the covalidation model is the expedited analytical method qualification of both the transferring and receiving laboratories.


Kieran O’Connor

Latest:

Spectroscopy Facilitates Lean Analysis

Spectroscopic-based control methods were introduced as equivalent alternative methods, first to a gas chromatographic method to monitor an in-process solvent exchange step and second to a potentiometric titration method to release a process input material for drug substance manufacturing.


Bikash Chatterjee

Latest:

The Impact of AI on Pharma

CPHI’s Annual Report predicts huge impact of AI on drug development and manufacturing.



David M. Marks

Latest:

GMP Facility Modernization: Opportunities for Successful Implementation

The DME Facility Focus survey revealed best practices for coping with the challenges of aging facilities and implementing facility modernization.


T. Van Den Kerkhof

Latest:

Understanding Fluidized-Bed Granulation

This study demonstrates the beneficial use of a spatial-filter velocimetry particle-size analyzer during granulation.


Shana K. Cyr

Latest:

Combination Products: Regulatory and Patent Issues You Should Consider Now

The authors discuss regulatory and patent issues with combination products.


Paula Miller

Latest:

Combination Products: Regulatory and Patent Issues You Should Consider Now

The authors discuss regulatory and patent issues with combination products.